CPRC
MPT

Consolidated Portfolio Review Corp’s Medical Properties Trust MPT Stock Holding History

Consolidated Portfolio Review Corp’s Portfolio MPT Stock Details MPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-33,895
Closed -$314K – 323
2023
Q2 		$314K Buy
33,895
+2,412
+8% +$20.4K 0.07% 222
2023
Q1 		$259K Buy
+31,483
New +$348K 0.07% 229

Other funds holding MPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Cohen & Steers
Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CIM
Centersquare Investment Management Conshohocken, Pennsylvania $9.67B AUM 5.55% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Consolidated Portfolio Review Corp's MPT Position: Q3 2023 in Review

Consolidated Portfolio Review Corp sold out of Medical Properties Trust (MPT) in Q3 2023, closing a stake of 33,895 shares — an estimated $314K sold.

Consolidated Portfolio Review Corp first reported a position in MPT in Q1 2023 and held it in 2 quarters. The position peaked at $314K in Q2 2023. 541 funds tracked by Wall St. Rank hold MPT as of Q3 2023.

  • Consolidated Portfolio Review Corp reported no remaining Medical Properties Trust position as of Q3 2023 after selling out during the quarter.
  • Consolidated Portfolio Review Corp sold 33,895 Medical Properties Trust shares in Q3 2023, an estimated $314K.
  • Consolidated Portfolio Review Corp first reported a position in Medical Properties Trust in Q1 2023 and held it in 2 quarters.
  • Consolidated Portfolio Review Corp's Medical Properties Trust position peaked at $314K in Q2 2023.
  • 541 funds tracked by Wall St. Rank held Medical Properties Trust as of Q3 2023.

Based on Consolidated Portfolio Review Corp's 13F filing for Q3 2023, filed 13 Nov 2023.